In an interview to CNBC-TV18, Alok Saxena, joint managing director of Elder Pharma says, he is bullish on the domestic market. “On the domestic front, we are still growing at about 25%. All our brands are growing at 25%. This segment will continue to be the major growth driver for the company,” he adds.
first published: Dec 28, 2011 03:09 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty extend surge to third day led by banking, IT stocks | Closing Bell
Tata Capital's Mega Rs 15,500 Cr IPO Kicks Off| Management On Future Outlook| IPO Watch Live
Live: Big IPOs, Q2 earnings season: Markets enter action-packed week | Opening Bell
The 23-Year-Old Struggling It Out As A Real Estate Broker | The Tenant
